MedPath

Efficacy and Safety Study of Individualized and Standardized Acupuncture Treatment for Knee Osteoarthritis

Not Applicable
Conditions
Osteoarthritis Knee
Interventions
Procedure: Individualized Acupuncture
Procedure: Standardized Acupuncture
Procedure: sham acupuncture
Other: Waiting
Registration Number
NCT01569230
Lead Sponsor
Eun Jung Kim
Brief Summary

The purpose of this study is to verify the efficacy and safety of acupuncture treatments (Individualized, Standardized acupuncture) for patients with knee osteoarthritis (OA).

Detailed Description

The investigators targeted the patients with knee OA. After treatment in 4 groups - individualized acupuncture treatment, standardized acupuncture treatment, sham-needle treatment, and waiting groups - the investigators will compare the effects of pain relieving and daily performing improvement. So the investigators will confirm the efficacy of acupuncture, and further the best treatment method. In addition, the investigators are going to evaluate the safety of abnormal reaction during the treatment.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
250
Inclusion Criteria
  1. At least 20 years of age, but below 80 years of age
  2. Knee pain from OA in one or both knees in the last 3 months or more
  3. Presence of knee OA diagnosed by an orthopedist based on American College of Rheumatology classification criteria
  4. Knee pain from OA in one or both knees rated > 4 cm on a 10 cm Visual Analog Scale (VAS)
  5. An understanding of the objectives and methods of the clinical trial, and willingness in completing the consent form.
  6. Those who are reliable and willing to cooperate in this test, and obey the restrictions for the next 3 months
Exclusion Criteria
  1. Trauma to or surgery on the knee(s) within 6 months prior to enrollment, causing pain or functional problems
  2. A history of prolotherapy, injection of hyaluronic acid or cortisone within the last 3 months
  3. A physical or laboratory finding indicating infection, presence of an autoimmune disease, or inflammatory arthritis
  4. Serious organic disease, and severe dysfunction due to the medical illness (e.g. Arrhythmia, Angina pectoris, Stroke, Asthma, etc.)
  5. More severe pain in regions other than the knee joint.
  6. Pregnant
  7. When researchers evaluate that it is not appropriate to participate in this clinical test

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Individualized acupunctureIndividualized AcupunctureThe patients in this group received individualized acupuncture prescribed by a certified Korean Medicine Doctor with more than 6 years of oriental medicine college education and 2 years of clinical experience. The acupuncture formulas were composed based on the pattern diagnosis, which is an unique diagnosis system of Oriental Medicine.
Standardized AcupunctureStandardized AcupunctureThe patients in this group received standardized acupuncture treatment using the same acupuncture points, applied by a certified Korean Medicine Doctor with more than 6 years of oriental medicine college education and 2 years of clinical experience. The acupuncture formulas were composed based on literature review of RCTs.
Sham acupuncturesham acupunctureNon-penetrating acupuncture device, Park-sham acupuncture, was applied to the patients. The appearance of the acupuncture is same but the needles do not penetrate the skin.
WaitingWaitingNo interventions were applied to the patients in this group. Only assessments were made at each visit.
Primary Outcome Measures
NameTimeMethod
WOMAC (Western Ontario and McMaster Universities) Scale changeat 2nd(Baseline),8(after 3weeks of treatment),13th(after 6 weeks of treatment) and 14(follow up evaluation after 6 weeks from the last treatment) visit

WOMAC scale is checked by the patients. WOMAC scale is a tool to check of the disability, stiffness and pain by knee pain.

Secondary Outcome Measures
NameTimeMethod
100mm Pain Visual Analogue Scaleat 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13(after 6 weeks of treatment), and 14th(follow up evaluation after 6 weeks from the last treatment) visit

The patient is asked to indicate their perceived pain intensity along a 100 mm horizontal line, where '0' represents 'no pain' and '100', 'unbearable pain'.

6 Minute walk testat 2nd(Baseline),8(after 3weeks of treatment),13th(after 6 weeks of treatment) and 14(follow up evaluation after 6 weeks from the last treatment) visit

the distance of subject's 6 Minute walking

WOMAC painat 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13(after 6 weeks of treatment), and 14th(follow up evaluation after 6 weeks from the last treatment) visit

The pain part of WOMAC (Westren Ontario and McMaster Universities) Scale

Investigator global assessment(IGA)at 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13(after 6 weeks of treatment), and 14th(follow up evaluation after 6 weeks from the last treatment) visit

5 Grading of Investigator(1=Very good, 2=good, 3=fair, 4=poor, 5=very poor)

Patient global assessment(PGA)at 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13(after 6 weeks of treatment), and 14th(follow up evaluation after 6 weeks from the last treatment) visit

5 Grading of Investigator(1=Very good, 2=good, 3=fair, 4=poor, 5=very poor)

Adverse Eventsat 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13th(end of treatment) visit

Any unpredicted symptoms were checked at each follow up visit and if any, the symptom, time of occurrence, and length of duration were recorded and reported.

Trial Locations

Locations (1)

Donnguk University Oriental Medical center

🇰🇷

Goyang, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath